When people were dying from AIDS in the 1980s and 90s, Congress found a way to expedite the drug approval process and saved countless lives. Established in 1992, the Accelerated Approval Program allows the FDA to speed approval of drugs for patients with serious and life-threatening conditions.
The Latest Episode:
- John Crowley, Executive Chairman, Amicus Therapeutics
- Emil D. Kakkis, CEO and President, Ultragenyx
- Cartier Esham, Chief Scientific Officer, BIO
- Duane Schulthess, CEO, Vital Transformation
In this episode we talk with the father of children with a rare disease, a company CEO working to treat rare diseases and two policy experts on Accelerated Approval.